Akero Therapeutics Inc Share Price

NASDAQ: AKRO

Small Cap

$42.60

-0.25

(-0.58%)

as on September 17, 2025 at 1:29 am IST

$₹

Akero Therapeutics Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$42.49
Day's Price Range
$43.51
$42.6
0.26%
Downside
2.14%
Upside
52 Week's Low
52 Week's High
$21.34
52-Week Price Range
$58.4
$42.6
49.91%
Downside
37.09%
Upside

Akero Therapeutics Inc share price movements today

Previous Close: $42.85
Open: $42.88
Volume: 785.7K
Day's Low - High: $42.49 - $43.51
52 Week Low - High: $21.34 - $58.4

Akero Therapeutics Inc Historical Returns

1 Month Return: -13.73 %
3 Month Return: -23.1 %
1 Year Return: + 59.91 %
3 Year Return: + 63.72 %
5 Year Return: + 17.81 %

Akero Therapeutics Inc Stock Fundamentals & Key Indicators

Check Akero Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.4B

EPS (TTM)

-3.7181

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-321.5M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

20438600.00%

Akero Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Akero Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Akero Therapeutics Inc	BUY	$3.4B	17.81%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Akero Therapeutics Inc Stock including INR - Dollar returns

The Akero Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Akero Therapeutics Inc investment value today

Current value as on today

₹1,64,777

Returns

₹64,777

(+64.78%)

Returns from Akero Therapeutics Inc Stock

₹59,910 (+59.91%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Akero Therapeutics Inc Stock

Based on 16 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Akero Therapeutics Inc. Average target price of $77.3

Akero Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Akero Therapeutics Inc.

What analysts predicted

44.89%UPSIDE

Target Price

$77.3

Current Price

$42.6

Analyzed by

16 Analysts

Target

$77.30

Akero Therapeutics Inc target price $77.3, a slight upside of 44.89% compared to current price of $42.6. According to 16 analysts rating.

Akero Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Akero Therapeutics Inc Stock has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:-18% versus previous 30 day period

Akero Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	0	-	-	-	0	-	-
Gross Profit	0	0	0	0	0	0	0	0	-	-
Operating Income	-28	-35	-46	-61	-59	-65	-81	-78	-80	-80
EBITDA	-25	-30	-38	-54	-52	-54	-71	-68	-69	-69
Interest Expense	0	0	0	0	0	1	1	1	1	1
Depreciation	0	0	0	0	0	0	0	0	-	-
Income Before Tax	-25	-31	-39	-55	-53	-55	-72	-70	-70	-70
Income Tax Expense	-2	6	8	-12	0	0	-	-	-	-
Net Income	-23	-31	-39	-55	-53	-55	-72	-70	-70	-70
Net Profit Margin	0.00%	0.00%	0.00%	-19431.69%	0.00%	0.00%	0.00%	-1750600.00%	0.00%	0.00%

Akero Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-80	-100	0	0	0
Operating Income	-4	-13	-45	-80	-100	-115	-172	-285
EBITDA	0	-68	-45	-80	-100	-111	-148	-285
Interest Expense	-	-	-	-	0	0	3	4
Depreciation	-	-	-	0	0	0	0	0
Income Before Tax	-4	-81	-43	-79	-100	-112	-151	-252
Income Tax Expense	-4	-68	-1	0	0	-3	-	-
Net Income	-4	-81	-43	-79	-100	-108	-151	-252
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Akero Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-31	-39	-55	-53	-55	-72	-70	-70	-70
Operating Cash Flow	-22	-49	-48	-35	-57	-70	-67	-67	-48
Investing Cash Flow	-128	-125	12	57	-255	73	15	-482	79
Financing Cash Flow	336	0	0	366	0	3	75	395	3
Change in Cash	186	-174	-35	389	-313	5	24	-154	34

Akero Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-81	-43	-79	-100	-112	-151	-252
Operating Cash Flow	-4	-35	-70	-79	-92	-145	-230
Investing Cash Flow	-5	-71	-9	42	-63	-223	-109
Financing Cash Flow	85	95	203	0	255	353	445
Change in Cash	75	-11	122	-36	99	-15	106

Global Institutional Holdings in Akero Therapeutics Inc

Funds	Holdings
RTW INVESTMENTS, LLC	9.28%
HHG PLC	8.84%
BlackRock Inc	7.82%
Wellington Management Company LLP	7.42%
General Atlantic Llc	6.54%

See all

Insights on Akero Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.2% return, outperforming this stock by 7.4%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 46.8%
NEGATIVE IMPACT
Price Dip
In the last 1 month, AKRO stock has moved down by -13.2%

About Akero Therapeutics Inc

akero therapeutics is developing best-in-class medicines that restore metabolic balance to treat non-alcoholic steatohepatitis (nash) and other serious metabolic diseases. akero's lead clinical program, akr-001, is a long-acting fc fusion modified fgf21 protein and potential best-in-class treatment for nash. akr-001 builds upon two decades of work on fgf21 biology. it is designed to affect both the liver and adipose tissue, reducing liver fat and suppressing inflammation and fibrosis.

Organisation	Akero Therapeutics Inc
Headquarters	601 Gateway Boulevard, South San Francisco, CA, United States, 94080
Industry	Health Technology
CEO	Dr. Andrew Cheng M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Akero Therapeutics Inc

Name	Title
Dr. Jonathan M. Young J.D., Ph.D.	Co-Founder, Executive VP, COO & Secretary
Mr. Scott A. Gangloff	Chief Technical Officer
Dr. Timothy Rolph Ph.D.	Co-Founder & Chief Scientific Officer
Mr. Thomas Ross	Senior VP & Head of Legal
Mr. John J. Schembri	Senior VP & Head of Finance
Mr. Patrick Lamy	Senior Vice President of Commercial Strategy
Dr. Andrew Cheng M.D., Ph.D.	President, CEO & Director
Mr. William R. White J.D.	Executive VP, CFO, Treasurer & Head of Corporate Development
Ms. Catriona Yale	Executive VP & Chief Development Officer

FAQs

What is Akero Therapeutics Inc share price today?

Akero Therapeutics Inc share price today is $42.6 as on September 17, 2025 at 1:29 am IST at the close of the market. Akero Therapeutics Inc share today touched a day high of $43.51 and a low of $42.49.

What is the 52 week high and 52 week low for Akero Therapeutics Inc share?

Akero Therapeutics Inc share touched a 52 week high of $58.4 on January 27, 2025 and a 52 week low of $21.34 on January 14, 2025. Akero Therapeutics Inc stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $42.6,which is 27.05% down from its 52 week high and 99.63% up from its 52 week low.

What is Akero Therapeutics Inc's market capitalisation today?

Akero Therapeutics Inc market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Akero Therapeutics Inc Stock (AKRO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Akero Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Akero Therapeutics Inc Shares that will get you 0.0352 shares as per Akero Therapeutics Inc share price of $42.6 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Akero Therapeutics Inc Stock (AKRO) from India?

Indian investors can start investing in Akero Therapeutics Inc (AKRO) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 12:37 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Akero Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 12:37 pm IST). Based on Akero Therapeutics Inc share’s latest price of $42.6 as on September 17, 2025 at 1:29 am IST, you will get 0.2347 shares of Akero Therapeutics Inc. Learn more about fractional shares .

What are the returns that Akero Therapeutics Inc has given to Indian investors in the last 5 years?

Akero Therapeutics Inc stock has given 17.81% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?